Management of atrial fibrillation still suboptimal in Europe
Thursday, December 19, 2013 - 14:01
in Health & Medicine
Atrial fibrillation (AF) is the commonest cardiac rhythm disorder in Europe, and each of us have a one-in-four lifetime risk of developing it. Statistics show that oral anticoagulant use has increased, but new oral anticoagulant (NOAC) use is still low. Authors also concluded that compliance with treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal.